Cargando…
Anticancer evaluation of N-benzoyl-3-allylthiourea as potential antibreast cancer agent through enhances HER-2 expression
Breast cancer with HER-2 overexpression is sensitive to drugs which target the receptor or its kinase activity. Although the anti-HER-2 therapies commonly used have improved patient outcome, resistance usually occurs. In this present study, we investigated a modification of the chemical structure of...
Autores principales: | Widiandani, Tri, Siswandono, Meiyanto, Edy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784947/ https://www.ncbi.nlm.nih.gov/pubmed/33425698 http://dx.doi.org/10.4103/japtr.JAPTR_77_20 |
Ejemplares similares
-
Computational Study of Bis-(1-(Benzoyl)-3-Methyl Thiourea) Platinum (II) Complex Derivatives as Anticancer Candidates
por: Ruswanto, Ruswanto, et al.
Publicado: (2023) -
Tris(allylthiourea-κS)bromidozinc(II) bromide
por: Sun, Hai-Qing, et al.
Publicado: (2011) -
Benzofuran as a promising scaffold for the synthesis of antimicrobial and antibreast cancer agents: A review
por: Khodarahmi, Ghadamali, et al.
Publicado: (2015) -
In vitro study of pinostrobin propionate and pinostrobin butyrate: Cytotoxic activity against breast cancer cell T47D and its selectivity index
por: Widiandani, Tri, et al.
Publicado: (2023) -
In vivo anticancer activity of benzoxazine and aminomethyl compounds derived from eugenol
por: Rudyanto, Marcellino, et al.
Publicado: (2023)